The effect of Praprofen eye drops on postoperative treatment of cataracts
普拉洛芬滴眼液应用于白内障术后治疗的效果

摘要

目的 分析白内障患者术后予以普拉洛芬滴眼液治疗的临床效果。方法 纳入我院2022年7月至2023年7月行手术治疗白内障手术患者，全体90例入组对象随机分成两组，每组平均45例。术后均予以药物治疗，对照组使用氟米龙滴眼液，观察组使用普拉洛芬滴眼液。从术后角膜水肿、结膜充血症状以及视网膜结构恢复情况进行综合评估。结果 两组术后1月时角膜水肿、结膜充血症状评分对比各组术后1d时均出现下降趋势（P＜0.05）；且观察组上述评分较对照组下降更明显（P＜0.05）。两组术后1月时，黄斑中心区视网膜厚度（MFRT）对比各组术后1d时均出现下降趋势，黄斑中心凹视网膜厚度（CMT）出现升高趋势（P＜0.05）；且观察组MFRT、CMT仍较对照组更低（P＜0.05）。结论 白内障患者术后予以普拉洛芬滴眼液治疗可有效减轻角膜水肿、结膜充血症状，改善视网膜结构。

Abstract

Objective To analyze the clinical effect of praprofen eye drops in cataract patients after surgery.
Methods All 90 patients who underwent cataract surgery in our hospital from July 2022 to July 2023 were randomly divided into two groups, with an average of 45 cases in each group. The patients in the control group were treated with flumiron eye drops and the observation group with praprofen eye drops. The postoperative symptoms of corneal edema, conjunctival congestion and retinal structural recovery were evaluated comprehensively.
Results The score of corneal edema and conjunctival congestion 1 month after surgery showed a decreasing trend 1 day after surgery (P < 0.05). The above scores in the observation group were significantly lower than those in the control group (P < 0.05). At 1 month after surgery, macular central retinal thickness (MFRT) showed a decreasing trend, and macular foveal retinal thickness (CMT) showed an increasing trend compared with each group at 1 day after surgery (P < 0.05). MFRT and CMT in the observation group were lower than those in the control group (P < 0.05).
Conclusion   Praprofen eye drops can effectively reduce corneal edema and conjunctival congestion and improve retinal structure in cataract patients.